Page 1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington , D.C. 20549 FORM 20 - F REGISTRATION STATEMENT PURSUANT TO SECTION 12 ( B ) OR 12 ( G ) OF THE SECURITIES EXCHANGE ACT OF 1934 OR × ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 ( D ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31 , 2026 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 ( D ) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15 ( D ) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of event requiring this shell company report : For the transition period from to Commission file number : 001-42907 Charming Medical Limited ( Exact name of Registrant as specified in its charter ) British Virgin Islands ( Jurisdiction of incorporation or organization ) Units 1803-1806 , 18 / F , Hang Lung Centre 2-20 Paterson Street , Causeway Bay , Hong Kong ( Address of principal executive offices ) Kit Wong Tel : +852 2116 1492 Units 1803-1806 , 18 / F , Hang Lung Centre 2-20 Paterson Street , Causeway Bay , Hong Kong ( Name , Telephone , E - mail and / or Facsimile number and Address of Company Contact Person ) Securities registered or to be registered pursuant to Section 12 ( b ) of the Act : Title of each class Class A Ordinary Shares , par value $ 0.0001 per share Trading Symbol ( s ) MCTA Name of each exchange on which registered The Nasdaq Stock Market LLC ( Nasdaq Capital Market ) Securities registered or to be registered pursuant to Section 12 ( g ) of the Act : None Securities for which there is a reporting obligation pursuant to Section 15 ( d ) of the Act : None Indicate the number of outstanding shares of each of the issuer's classes of capital or common stock as of the close of the period covered by the annual report : 15,178,000 Class A Ordinary Shares and 2,000,000 Class B Ordinary Shares issued and outstanding as of March 31 , 2026 .